Ocaliva 5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FDQZX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,691
Award facts
- Contract value 100% obligated
- $12,690.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,690.76 by the Defense Logistics Agency (DLA) on August 28, 2025. The delivery order, issued without set-aside designation, covers the supply of Ocaliva 5 mg tablets (30-count units) with an ultimate completion date of September 19, 2025. Performance will be executed at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The contract vehicle enables DLA to procure branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various pharmaceutical categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of delivery orders with the DLA, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FDQZX?
SPE2DB25FDQZX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FDQZX worth?
The government has obligated $12,691 on SPE2DB25FDQZX.
Is contract SPE2DB25FDQZX an order under another contract?
Yes. SPE2DB25FDQZX is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQZX competed?
The extent of competition for SPE2DB25FDQZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award